ACET Adicet Bio, Inc.
$9.52▼ -0.10%
Healthcare
Other
After hours
$9.40▼ -1.26%
Sep 11, 7:30 PM ET
Volume 119.3K
Avg Volume (10D) 109.5K
Key Metrics & Fundamentals
Market Cap
$89.12M
P/E Ratio
–
Div Yield
–%
52W Range
6.01 - 17.44
% vs 50 MA
8.24%
% vs 200 MA
17.93%
RSI-14
59.4
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.80
Free Cash Flow
-$20.03M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$19.99M
COGS
–
Operating Exp
$22.30M
Operating Income
-$22.30M
EBIT
-$22.30M
Pretax Income
-$21.22M
Net Income
-$21.36M
EPS (Diluted)
-1.99
Price & Volume History
Loading chart…
Recent News
Wall Street Analysts See a 258.21% Upside in Adicet Bio (ACET): Can the Stock Really Move This High?
Zacks · Sep 3, 2026 1:55 PM
Is Adicet Bio (ACET) Outperforming Other Medical Stocks This Year?
Zacks · Sep 3, 2026 1:40 PM
Adicet Bio to Participate in Fireside Chat at H.C. Wainwright 28th Annual Global Investment Conference
Business Wire · Sep 2, 2026 8:00 PM
Adicet Bio Announces Completion of Last Patient Visit for Planned Analysis of prula-cel (formerly ADI-001) Study in Patients with Systemic Lupus Erythematosus With or Without Lupus Nephritis and Provides Corporate Update
Business Wire · Sep 1, 2026 11:00 AM
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Business Wire · Aug 31, 2026 9:39 PM
Adicet Bio Gets FDA Clearance for IND for ADI-212 in prostate cancer
MT Newswires · Aug 27, 2026 9:00 PM
Adicet Bio Announces FDA Clearance of IND Application for ADI-212
Business Wire · Aug 27, 2026 8:00 PM
Here's Why You Should Add ACET Stock to Your Portfolio Now
Zacks · Aug 24, 2026 2:09 PM
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
Zacks · Aug 18, 2026 1:40 PM
Wall Street Analysts Think Adicet Bio (ACET) Could Surge 301.57%: Read This Before Placing a Bet
Zacks · Aug 14, 2026 1:55 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ACET's money flow as a full page
Social Sentiment
No Reddit posts found for ACET.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.